Role of Leukotrienes and Leukotriene Modifiers in Asthma
Leukotrienes (LTs), including cysteinyl LTs (CysLTs) and LTB4, are potent lipid mediators that are pivotal in the pathophysiology of asthma phenotypes. At least two receptor subtypes for CysLTs – CysLT1 and CysLT2 – have been identified. Most of the pathophysiological effects of CysLTs in asthma, in...
Main Author: | Paolo Montuschi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-06-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/3/6/1792/ |
Similar Items
-
Upregulation of Leukotriene Receptors in Gastric Cancer
by: Daniel Schubert, et al.
Published: (2011-08-01) -
Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model
by: Mariko Ujino, et al.
Published: (2017-09-01) -
Effect of a leukotriene receptor antagonist pranlukast hydrate, on airway inflammation airway hyperresponsiveness in patients with moderate to severe asthma
by: Kiyoko Wada, et al.
Published: (2000-01-01) -
Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer
by: Lorraine Burke, et al.
Published: (2016-09-01) -
Additive effect of cysteinyl leukotriene or thromboxane modifiers to inhaled corticosteroids in asthmatic patients
by: Shigeharu Myou, et al.
Published: (2004-01-01)